To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the causes of recent supply shortages of Ganfort and Toptiqom.
We have been in direct contact with Allergan, the manufacturer of Ganfort eyedrops, who has advised that recent manufacturing issues have resulted in a delay to deliveries. These issues are now resolved and supplies are currently available. Allergan expects a full recovery by the end of February 2019.
Santen, the manufacturer of Taptiqom eyedrops, has advised that they are not aware of and do not anticipate any supply issues affecting this product.